view article
Figure 1
Macrocyclic `beyond Rule of 5' (bRo5) molecules used to validate the HAMR method: (a) paritaprevir, (b) grazoprevir and (c) corilagin.

IUCrJ
Volume 13| Part 3| May 2026| Pages 273-281
ISSN: 2052-2525
https://doi.org/10.1107/S2052252526002095